Two Sigma Advisers’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $583K | Sell |
31,117
-10,811
| -26% | -$202K | ﹤0.01% | 1682 |
|
2025
Q1 | $754K | Sell |
41,928
-21,200
| -34% | -$381K | ﹤0.01% | 1599 |
|
2024
Q4 | $1.06M | Buy |
63,128
+24,400
| +63% | +$410K | ﹤0.01% | 1428 |
|
2024
Q3 | $627K | Buy |
38,728
+4,399
| +13% | +$71.2K | ﹤0.01% | 1612 |
|
2024
Q2 | $282K | Sell |
34,329
-27,990
| -45% | -$230K | ﹤0.01% | 2094 |
|
2024
Q1 | $922K | Sell |
62,319
-3,541
| -5% | -$52.4K | ﹤0.01% | 1620 |
|
2023
Q4 | $955K | Sell |
65,860
-37,269
| -36% | -$540K | ﹤0.01% | 1666 |
|
2023
Q3 | $1.11M | Sell |
103,129
-116,440
| -53% | -$1.26M | ﹤0.01% | 1473 |
|
2023
Q2 | $2.83M | Sell |
219,569
-17,100
| -7% | -$221K | 0.01% | 1022 |
|
2023
Q1 | $3.12M | Buy |
236,669
+56,770
| +32% | +$749K | 0.01% | 1029 |
|
2022
Q4 | $2.7M | Sell |
179,899
-14,930
| -8% | -$224K | 0.01% | 1074 |
|
2022
Q3 | $2.3M | Buy |
194,829
+163,270
| +517% | +$1.93M | 0.01% | 1100 |
|
2022
Q2 | $357K | Buy |
31,559
+26,380
| +509% | +$298K | ﹤0.01% | 2066 |
|
2022
Q1 | $155K | Sell |
5,179
-51,480
| -91% | -$1.54M | ﹤0.01% | 2425 |
|
2021
Q4 | $1.5M | Sell |
56,659
-124,810
| -69% | -$3.31M | ﹤0.01% | 1331 |
|
2021
Q3 | $6.59M | Sell |
181,469
-9,500
| -5% | -$345K | 0.02% | 667 |
|
2021
Q2 | $8.29M | Sell |
190,969
-45,980
| -19% | -$2M | 0.02% | 641 |
|
2021
Q1 | $8.1M | Buy |
236,949
+201,000
| +559% | +$6.87M | 0.02% | 653 |
|
2020
Q4 | $1.26M | Sell |
35,949
-67,550
| -65% | -$2.36M | ﹤0.01% | 1465 |
|
2020
Q3 | $2.48M | Buy |
103,499
+17,910
| +21% | +$430K | 0.01% | 1052 |
|
2020
Q2 | $1.57M | Buy |
85,589
+4,720
| +6% | +$86.4K | ﹤0.01% | 1344 |
|
2020
Q1 | $1.26M | Buy |
80,869
+2,220
| +3% | +$34.6K | ﹤0.01% | 1354 |
|
2019
Q4 | $1.68M | Buy |
78,649
+11,830
| +18% | +$253K | ﹤0.01% | 1309 |
|
2019
Q3 | $1.25M | Buy |
66,819
+10,580
| +19% | +$198K | ﹤0.01% | 1336 |
|
2019
Q2 | $1.47M | Buy |
56,239
+5,000
| +10% | +$131K | ﹤0.01% | 1341 |
|
2019
Q1 | $1.32M | Buy |
51,239
+33,940
| +196% | +$872K | ﹤0.01% | 1401 |
|
2018
Q4 | $398K | Sell |
17,299
-3,600
| -17% | -$82.8K | ﹤0.01% | 1860 |
|
2018
Q3 | $671K | Buy |
20,899
+5,090
| +32% | +$163K | ﹤0.01% | 1678 |
|
2018
Q2 | $447K | Buy |
15,809
+1,090
| +7% | +$30.8K | ﹤0.01% | 1962 |
|
2018
Q1 | $521K | Buy |
14,719
+4,440
| +43% | +$157K | ﹤0.01% | 1800 |
|
2017
Q4 | $399K | Buy |
10,279
+2,400
| +30% | +$93.2K | ﹤0.01% | 1849 |
|
2017
Q3 | $200K | Sell |
7,879
-1,460
| -16% | -$37.1K | ﹤0.01% | 2055 |
|
2017
Q2 | $255K | Sell |
9,339
-830
| -8% | -$22.7K | ﹤0.01% | 2044 |
|
2017
Q1 | $337K | Sell |
10,169
-9,750
| -49% | -$323K | ﹤0.01% | 2051 |
|
2016
Q4 | $474K | Sell |
19,919
-7,390
| -27% | -$176K | ﹤0.01% | 1895 |
|
2016
Q3 | $1M | Buy |
27,309
+3,120
| +13% | +$114K | ﹤0.01% | 1356 |
|
2016
Q2 | $539K | Sell |
24,189
-3,930
| -14% | -$87.6K | ﹤0.01% | 1480 |
|
2016
Q1 | $585K | Sell |
28,119
-510
| -2% | -$10.6K | ﹤0.01% | 1399 |
|
2015
Q4 | $867K | Sell |
28,629
-2,820
| -9% | -$85.4K | 0.01% | 1093 |
|
2015
Q3 | $790K | Sell |
31,449
-3,250
| -9% | -$81.6K | 0.01% | 1115 |
|
2015
Q2 | $1.11M | Buy |
34,699
+6,220
| +22% | +$200K | 0.01% | 1078 |
|
2015
Q1 | $1.02M | Buy |
28,479
+2,730
| +11% | +$97.5K | 0.01% | 1065 |
|
2014
Q4 | $585K | Buy |
25,749
+2,850
| +12% | +$64.8K | ﹤0.01% | 1340 |
|
2014
Q3 | $444K | Sell |
22,899
-1,020
| -4% | -$19.8K | ﹤0.01% | 1256 |
|
2014
Q2 | $868K | Buy |
23,919
+1,650
| +7% | +$59.9K | 0.01% | 1067 |
|
2014
Q1 | $863K | Sell |
22,269
-1,350
| -6% | -$52.3K | 0.01% | 958 |
|
2013
Q4 | $672K | Buy |
+23,619
| New | +$672K | 0.01% | 1083 |
|